Free shipping on all orders over $ 500

DOTA-JR11

Cat. No. M41945

All AbMole products are for research use only, cannot be used for human consumption.

DOTA-JR11 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

DOTA-JR11 is a somatostatin receptor 2 (SSTR2)antagonist.

Chemical Information
Molecular Weight 1689.27
Formula C74H98ClN19O21S2
CAS Number 1039726-31-2
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Maryana Handula et al. EJNMMI Radiopharm Chem. First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs

[2] Eric J Meester et al. J Nucl Cardiol. Imaging inflammation in atherosclerotic plaques, targeting SST2 with [111In]In-DOTA-JR11

Related Somatostatin Receptor Products
L-817818 

L-817818 is a potent and subtype-selective agonist of the somatostatin receptor.

NNC 26-9100 

NNC 26-9100 is a selective somatostatin sst4 receptor full agonist (Ki: 6 nM, EC50: 2 nM).

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 is a selective non-peptide human somatostatin receptor subtype 2 (sst2) agonist.

TT-232

TT-232 (CAP-232), a somatostatin derivative, is a peptide SSTR1/SSTR4 agonist.

Cyclosomatostatin

Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: DOTA-JR11 supplier, Somatostatin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.